Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dentsply Sirona (XRAY) Research & Development (2020 - 2025)

Historic Research & Development for Dentsply Sirona (XRAY) over the last 6 years, with Q3 2025 value amounting to $37.0 million.

  • Dentsply Sirona's Research & Development fell 750.0% to $37.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.0 million, marking a year-over-year decrease of 843.37%. This contributed to the annual value of $165.0 million for FY2024, which is 1032.61% down from last year.
  • Dentsply Sirona's Research & Development amounted to $37.0 million in Q3 2025, which was down 750.0% from $37.0 million recorded in Q2 2025.
  • Over the past 5 years, Dentsply Sirona's Research & Development peaked at $49.0 million during Q4 2021, and registered a low of $36.0 million during Q1 2025.
  • Moreover, its 5-year median value for Research & Development was $42.0 million (2024), whereas its average is $42.3 million.
  • In the last 5 years, Dentsply Sirona's Research & Development surged by 11500.0% in 2021 and then plummeted by 1632.65% in 2024.
  • Over the past 5 years, Dentsply Sirona's Research & Development (Quarter) stood at $49.0 million in 2021, then fell by 12.24% to $43.0 million in 2022, then changed by 0.0% to $43.0 million in 2023, then fell by 2.33% to $42.0 million in 2024, then fell by 11.9% to $37.0 million in 2025.
  • Its Research & Development stands at $37.0 million for Q3 2025, versus $37.0 million for Q2 2025 and $36.0 million for Q1 2025.